2
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Phase 1
1
Status
Recruiting
1
Active not recruiting
1
Sponsor Class
OTHER
1
INDUSTRY
1
Study Type
Interventional
2
Sponsor
Cancer Type
Genitourinary
2
Conditions
Prostatic Neoplasms
28
Neoplasms
3
Neoplasm Metastasis
3
Metastatic Castration-Resistant Prostate Cancer (mCRPC)
2
Urogenital Neoplasms
1
Prostatic Diseases
1
Prostate Cancer Metastatic
1
Neoplasms, Glandular and Epithelial
1
Metastatic Castration-resistant Prostate Cancer
1
Metastatic Castrate-resistant Prostate Cancer
1
Hormone-Refractory Prostate Cancer
1
Genital Neoplasms, Male
1
Castrate Refractory Metastatic Prostate Cancer (mCRPC)
1
Carcinoma
1
Adenocarcinoma of the Prostate
1
Adenocarcinoma
1
Interventions
sipuleucel-T
2
enzalutamide
2
pamiparib
1
gallium 68 PSMA-11
1
fluzoparib
1
Vancomycin
1
Prednisone
1
Metronidazole
1
Docetaxel
1
Ciprofloxacin
1
Amoxicillin
1
Abiraterone Acetate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Metastatic Castration-Resistant Prostate Cancer (mCRPC)
×
sipuleucel-T
×
Clear all
NCT05806814
2026-05-27
OU-SCC-EXCITE
University of Oklahoma
Phase 1
Active not recruiting
15 enrolled
NCT06134232
2025-08-27
ProvONE
Dendreon
Phase 2
Recruiting
400 enrolled